In a breast cancer model, expansion of adoptively transferred tumor antigen-specific T cells was mediated by DC engagement through a combination therapy of Flt3L, radiotherapy, poly(I:C), and a CD40 agonist (176). This evidence concerns the gene FLT3LG and neoplasm.